Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8322 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8052 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7927 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7902 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7529 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7357 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7232 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7232 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7062 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7029 |
Intermediate Similarity |
NPD6685 |
Approved |
0.702 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7013 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD8485 |
Approved |
0.6972 |
Remote Similarity |
NPD6858 |
Approved |
0.6972 |
Remote Similarity |
NPD7094 |
Approved |
0.6954 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6939 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD5126 |
Approved |
0.6937 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6929 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD2182 |
Approved |
0.6894 |
Remote Similarity |
NPD6190 |
Approved |
0.6883 |
Remote Similarity |
NPD3764 |
Approved |
0.6882 |
Remote Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5951 |
Approved |
0.6867 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6867 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD4965 |
Approved |
0.6864 |
Remote Similarity |
NPD4966 |
Approved |
0.6864 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD5735 |
Approved |
0.6859 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6849 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6845 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD5740 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6085 |
Phase 2 |
0.6833 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6832 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD6653 |
Approved |
0.6812 |
Remote Similarity |
NPD5765 |
Approved |
0.6807 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD4140 |
Approved |
0.6786 |
Remote Similarity |
NPD37 |
Approved |
0.6784 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6768 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6752 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6746 |
Remote Similarity |
NPD7819 |
Suspended |
0.6733 |
Remote Similarity |
NPD6287 |
Discontinued |
0.673 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6728 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6725 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6705 |
Remote Similarity |
NPD7228 |
Approved |
0.6691 |
Remote Similarity |
NPD5738 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD7009 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6685 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2532 |
Approved |
0.6667 |
Remote Similarity |
NPD6912 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD2533 |
Approved |
0.6667 |
Remote Similarity |
NPD2534 |
Approved |
0.6667 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6648 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6646 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6643 |
Remote Similarity |
NPD164 |
Approved |
0.6629 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6626 |
Remote Similarity |
NPD7003 |
Approved |
0.6622 |
Remote Similarity |
NPD7516 |
Approved |
0.6608 |
Remote Similarity |
NPD5402 |
Approved |
0.6607 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD6799 |
Approved |
0.6604 |
Remote Similarity |
NPD6353 |
Approved |
0.66 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6594 |
Remote Similarity |
NPD1238 |
Approved |
0.659 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6588 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6584 |
Remote Similarity |
NPD7137 |
Phase 2 |
0.6579 |
Remote Similarity |
NPD7507 |
Approved |
0.6577 |
Remote Similarity |
NPD9545 |
Approved |
0.6575 |
Remote Similarity |
NPD8312 |
Approved |
0.6575 |
Remote Similarity |
NPD8313 |
Approved |
0.6571 |
Remote Similarity |
NPD1929 |
Approved |
0.6571 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6571 |
Remote Similarity |
NPD1930 |
Approved |
0.6571 |
Remote Similarity |
NPD6647 |
Phase 2 |
0.6564 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6558 |
Remote Similarity |
NPD7319 |
Approved |
0.6556 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6556 |
Remote Similarity |
NPD7240 |
Approved |
0.6554 |
Remote Similarity |
NPD4230 |
Clinical (unspecified phase) |
0.6554 |
Remote Similarity |
NPD7327 |
Approved |
0.6554 |
Remote Similarity |
NPD7328 |
Approved |
0.6552 |
Remote Similarity |
NPD5494 |
Approved |
0.655 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6543 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6538 |
Remote Similarity |
NPD7055 |
Discontinued |
0.6528 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6524 |
Remote Similarity |
NPD3750 |
Approved |
0.6522 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6519 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6516 |
Remote Similarity |
NPD5647 |
Approved |
0.6513 |
Remote Similarity |
NPD3092 |
Approved |
0.6513 |
Remote Similarity |
NPD4807 |
Approved |
0.6513 |
Remote Similarity |
NPD4806 |
Approved |
0.6512 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6506 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6503 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6494 |
Remote Similarity |
NPD1876 |
Approved |
0.6491 |
Remote Similarity |
NPD1934 |
Approved |
0.649 |
Remote Similarity |
NPD5305 |
Approved |
0.649 |
Remote Similarity |
NPD5306 |
Approved |
0.6488 |
Remote Similarity |
NPD5403 |
Approved |
0.6486 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6486 |
Remote Similarity |
NPD7115 |
Discovery |
0.6481 |
Remote Similarity |
NPD2438 |
Suspended |
0.6478 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6478 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6477 |
Remote Similarity |
NPD7315 |
Approved |
0.6475 |
Remote Similarity |
NPD2066 |
Phase 3 |
0.6474 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6467 |
Remote Similarity |
NPD5401 |
Approved |
0.6467 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6458 |
Remote Similarity |
NPD4061 |
Clinical (unspecified phase) |
0.6456 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6453 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD6362 |
Approved |
0.645 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6437 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6424 |
Remote Similarity |
NPD7503 |
Approved |
0.642 |
Remote Similarity |
NPD3748 |
Approved |
0.642 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6419 |
Remote Similarity |
NPD4766 |
Approved |
0.6415 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6412 |
Remote Similarity |
NPD3226 |
Approved |
0.641 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6408 |
Remote Similarity |
NPD1237 |
Approved |
0.6403 |
Remote Similarity |
NPD7638 |
Approved |
0.6398 |
Remote Similarity |
NPD3528 |
Clinical (unspecified phase) |
0.6395 |
Remote Similarity |
NPD4632 |
Approved |
0.6392 |
Remote Similarity |
NPD7095 |
Approved |
0.6391 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6387 |
Remote Similarity |
NPD1283 |
Approved |
0.6382 |
Remote Similarity |
NPD2932 |
Approved |
0.6382 |
Remote Similarity |
NPD3095 |
Discontinued |
0.6382 |
Remote Similarity |
NPD3019 |
Approved |
0.638 |
Remote Similarity |
NPD5405 |
Approved |
0.638 |
Remote Similarity |
NPD5404 |
Approved |
0.638 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.638 |
Remote Similarity |
NPD5406 |
Approved |
0.638 |
Remote Similarity |
NPD6099 |
Approved |
0.638 |
Remote Similarity |
NPD6100 |
Approved |
0.638 |
Remote Similarity |
NPD5408 |
Approved |
0.6379
|
Remote Similarity |
NPD3882 |
Suspended |